Our study investigated the relationship between the FCGR3A-V158F polymorphism and the clinicopathological characteristics of breast cancer patients, including age, family history, TNM staging, tumor size, lymph nodes, histopathological grade, and hormonal receptor status. Here, NR4A1 is linked to neoplasm.